End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.24 CNY | -0.36% | -5.32% | -17.99% |
06-20 | Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing | MT |
06-20 | Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules | MT |
Business Summary
Number of employees: 5,394
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Manufacturing
84.6
%
| 3,710 | 86.3 % | 4,263 | 84.6 % | +14.91% |
Commercial
14.5
%
| 523 | 12.2 % | 731 | 14.5 % | +39.77% |
Other
0.9
%
| 65 | 1.5 % | 47 | 0.9 % | -27.68% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.8
%
| 4,282 | 99.6 % | 4,967 | 99.8 % | +15.99% |
International
0.2
%
| 16 | 0.4 % | 9 | 0.2 % | -46.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jia Quan Sun
CEO | Chief Executive Officer | 47 | 10-05-25 |
Gang Sheng Li
DFI | Director of Finance/CFO | 44 | 22-10-25 |
Zi Liang Yang
BRD | Director/Board Member | 60 | 07-04-22 |
Zeng Liang Chen
BRD | Director/Board Member | 61 | 07-04-22 |
Qing Fu
BRD | Director/Board Member | 63 | 07-04-22 |
Ji Ye Wu
IRC | Investor Relations Contact | - | - |
Bao Zhou Duan
SEC | Corporate Secretary | 58 | 08-09-24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peng Sheng Sun
CHM | Chairman | 65 | 07-04-22 |
Qing Fu
BRD | Director/Board Member | 63 | 07-04-22 |
Zeng Liang Chen
BRD | Director/Board Member | 61 | 07-04-22 |
Zi Liang Yang
BRD | Director/Board Member | 60 | 07-04-22 |
Xiao Xing Yin
BRD | Director/Board Member | 58 | 07-03-31 |
Feng Shou Wang
CHM | Chairman | 62 | 07-04-22 |
Jia Quan Sun
CEO | Chief Executive Officer | 47 | 10-05-25 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 19-03-28 |
Yu Lan Li
BRD | Director/Board Member | 73 | 13-05-21 |
Guo Xiang Chen
BRD | Director/Board Member | 59 | 22-04-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,007,588,092 | 485,535,871 ( 48.19 %) | 0 | 48.19 % |
Company contact information
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Enhua Technology Building 31 Longhu West Road
221009, Xuzhou
+
http://www.nhwa-group.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.99% | 3.1B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- 002262 Stock
- Company Jiangsu Nhwa Pharmaceutical Co., LTD